| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |